The invention relates to a first composition providing at least one of acetic acid or butyric acid for controlling ketosis associated with a ketogenic diet in a subject adhering to a ketogenic diet, wherein controlling ketosis involves a) administering the first composition, b) optionally administering a second composition comprising propionic acid to reduce ketone production/administering a second composition comprising propionic acid provided that blood ketone levels are above 3 mmol/L.
A61K 31/194 - Acides carboxyliques, p.ex. acide valproïque ayant plusieurs groupes carboxyle, p.ex. acides succinique, maléique ou phtalique
A61K 31/455 - Acide nicotinique, c. à d. niacine; Ses dérivés, p.ex. esters, amides
A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p.ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle
A61K 47/36 - Polysaccharides; Leurs dérivés, p.ex. gommes, amidon, alginate, dextrine, acide hyaluronique, chitosane, inuline, agar-agar ou pectine
The invention relates to at least one of C4 or C6 fatty acids and optionally C2 fatty acids for enhancing ketosis associated with a ketogenic diet and/or preventing and/or treating resistance to a ketogenic diet, in a subject adhering to a ketogenic diet, wherein the at least one of C4 or C6 fatty acids and optionally C2 fatty acids are comprised in a non-ketogenic ketogenic diet-booster composition, or the at least C4 or C6 fatty acids and optionally C2 fatty acids are provided in non-ketogenic amounts by a dietary fibre blend comprised in a non-ketogenic ketogenic diet-booster composition.
Provided herein is a nutritional composition having therapeutically effective amounts of a combination of (a) hydrolysed whey protein and (b) MCT for use in (i) reducing tumor growth and/or (ii) for use in improving treatment efficacy in a subject having cancer and undergoing cancer treatment.
A61K 31/23 - Esters, p.ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p.ex. pravastatine d'acides ayant un groupe carboxyle lié à une chaîne d'au moins sept atomes de carbone
The invention provides a method, system, and computer program product for determining a maturation state of an infant aged between 0 and 120 months, comprising
The invention provides a method, system, and computer program product for determining a maturation state of an infant aged between 0 and 120 months, comprising
measuring at least one microbial biomarker from a set of measurable microbial biomarkers from a faecal sample of the infant,
The invention provides a method, system, and computer program product for determining a maturation state of an infant aged between 0 and 120 months, comprising
measuring at least one microbial biomarker from a set of measurable microbial biomarkers from a faecal sample of the infant,
determining a predicted age of the infant based on the at least one microbial biomarker,
The invention provides a method, system, and computer program product for determining a maturation state of an infant aged between 0 and 120 months, comprising
measuring at least one microbial biomarker from a set of measurable microbial biomarkers from a faecal sample of the infant,
determining a predicted age of the infant based on the at least one microbial biomarker,
wherein
The invention provides a method, system, and computer program product for determining a maturation state of an infant aged between 0 and 120 months, comprising
measuring at least one microbial biomarker from a set of measurable microbial biomarkers from a faecal sample of the infant,
determining a predicted age of the infant based on the at least one microbial biomarker,
wherein
the at least one microbial biomarker is selected from the set of measurable microbial biomarkers based on an analysis of the set of measurable microbial biomarkers as measured in faecal samples from a plurality of vaginally-born breast-fed infants at a plurality of ages,
The invention provides a method, system, and computer program product for determining a maturation state of an infant aged between 0 and 120 months, comprising
measuring at least one microbial biomarker from a set of measurable microbial biomarkers from a faecal sample of the infant,
determining a predicted age of the infant based on the at least one microbial biomarker,
wherein
the at least one microbial biomarker is selected from the set of measurable microbial biomarkers based on an analysis of the set of measurable microbial biomarkers as measured in faecal samples from a plurality of vaginally-born breast-fed infants at a plurality of ages,
the predicted age is obtained based on an evaluation of the at least one measured microbial biomarker using a function based on a plurality of corresponding at least one biomarkers measured in the faecal samples from the plurality of vaginally-born breast-fed infants at the plurality of ages.
G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicales; TIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
G16B 25/10 - Profilage de l’expression de gènes ou de protéines; Estimation ou normalisation de ratio d’expression
5.
NUTRITIONAL COMPOSITION COMPRISING UREA, NON-DIGESTIBLE OLIGOSACCHARIDE, AND BIFIDOBACTERIA
The invention relates to nutritional compositions for infants and in particular formulae for infants comprising human milk oligosaccharides, specific bifidobacteria, and urea as non-protein nitrogen source for improving the intestinal microbiota.
The invention relates to a nutritional composition comprising a combination of (i) omega-3 fatty acid DHA with (ii) vitamin B2 and (iii) vitamin D3 and one or more from (iv) choline or a salt thereof and/or choline esters; and (v) dietary fibres and/or dietary butyrate for use in the treatment of neurodegenerative diseases and/or neurotrauma, brain injury and/or brain damage. The invention also relates to a composition comprising a combination of DHA, vitamin B2, vitamin D3 with one or more from (iv) choline or a salt thereof and/or choline esters; and (v) dietary fibres and/or dietary butyrate.
A23L 33/21 - Adjonction de substances essentiellement non digestibles, p.ex. de fibres diététiques
A61K 31/202 - Acides carboxyliques, p.ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p.ex. acides stéarique, palmitique ou arachidique ayant au moins trois doubles liaisons, p.ex. acide linolénique
A61K 31/593 - Dérivés du 9,10-séco-cholestane, p.ex. cholécalciférol, vitamine D3
A61K 31/685 - Diesters d'acide du phosphore avec deux composés hydroxyle, p.ex. phosphatidylinositols un des composés hydroxylés ayant des atomes d'azote, p.ex. phosphatidylsérine, lécithine
A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p.ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence
A61L 33/00 - Traitement antithrombogénique d'articles chirurgicaux, p.ex. de sutures, cathéters, prothèses ou d'articles pour la manipulation ou le conditionnement du sang; Matériaux pour un tel traitement
7.
FERMENTED FORMULA WITH NON DIGESTIBLE OLIGOSACCHARIDES
The present invention relates to a fermented infant or follow on formula comprising non digestible oligosaccharides for decreasing duration of crying, reducing crying episodes, and incidence of colics in infants.
The invention relates to a neuroprotective composition comprising therapeutically effective amounts of a combination of pyruvate and citrate, for the treatment and/or prevention of neuronal damage in a subject suffering from or at risk of seizures.
A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p.ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle
A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
9.
Method and system for characterizing stool patterns of young infants
The invention provides a method of analysing the consistency of stool, including the steps of: providing stool of an infant, capturing, with a portable device comprising a camera, an image of the stool, providing the captured image to an input layer of a pre-trained convolutional neural network, CNN, processing the captured image using the CNN to obtain, from a final layer of the CNN, a classification vector and to obtain information about a predicted score from the classification vector, wherein at least the final layer of the CNN has been customized so that each element of the classification vector corresponds to a score of a stool analysis scale, and storing information about the predicted store.
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicales; TIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p.ex. basé sur des systèmes experts médicaux
A61B 5/00 - Mesure servant à établir un diagnostic ; Identification des individus
G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicales; TIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
10.
AMINO ACID METABOLITES FOR ENHANCED DETOXIFICATION ACTIVITY
The invention pertains to a method for increasing and/or improving detoxification capacity comprising increasing AhR activity and/or increasing expression of CYP1A1 in a human subject comprising administering a combination of indole lactic acid (ILA) and imidazole lactic acid (IML), therapeutically effective combinations of ILA and IML for use in improving detoxification and a nutritional composition that comprises ILA and IML for use in improving detoxification.
The present invention relates to a nutritional composition for infants and young children comprising a digestible carbohydrate component, wherein the digestible carbohydrate component comprises a mixture of free galactose and at least one digestible carbohydrate selected from the group consisting of maltodextrin and glucose syrup, and with reduced or no lactose and glucose. The invention also relates to the use of the nutritional composition according to the invention for improving body composition or body composition development.
A23C 9/20 - Produits diététiques à base de lait non couverts par les groupes
A23L 29/30 - Aliments ou produits alimentaires contenant des additifs; Leur préparation ou leur traitement contenant des hydrolysats d'amidon, p.ex. de la dextrine
A23L 33/00 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement
A61P 3/04 - Anorexigènes; Médicaments de l'obésité
A61P 37/00 - Médicaments pour le traitement des troubles immunologiques ou allergiques
12.
DEPHOSPHORYLATION OF SKIM MILK, ULTRA-FILTERED MILK OR MICELLAR CASEIN ISOLATE
The invention relates to a process for dephosphorylation of skim milk, ultra-filtered milk (UF milk) or micellar casein isolate (MCI) comprising (i) acidification of a skim milk, UF milk or MCI preferably not lower than pH 6.0, preferably between 6.0 and 6.7, (ii) cooling the acidified skim milk, UF milk or MCI to the temperature between 0 °C and 15°C, (iii) adding gluconate and/or maleate to the cooled skim milk, UF milk or MCI and, (iv) washing the skim milk, UF milk or MCI, to remove phosphorus, thus dephosphorylating the skim milk, UF milk or MCI, preferably to an extent that the total phosphorous content of the skim milk, UF milk or MCI is reduced with at least 20%, preferably 20-40%, more preferably 30 – 40 % compared to the material provided to step (i). The invention also relates to dephosphorylated MPC, MPI or MCI obtainable by the process of the invention, and to a liquid heat- sterilized enteral nutritional composition comprising 2.0 – 3.0 kcal/ml wherein 16 – 35 en% is provided by protein, the combination of caloric content and relative protein caloric content selected such that there is 10 – 18 g/100 ml protein, preferably 12 – 18 g/100 ml protein in the composition, wherein the protein comprises micellar casein (MC), whey protein (WP) and optionally caseinate (CAS), wherein there is at least 70 wt % MC and less than 15 wt % WP, based on total protein content, and wherein the composition has a total amount of phosphorous less than 192 mg/100 ml and/or 30 – 80 mg/100kcal, preferably at least 30 – 80 mg/100 kcal, most preferably less than 192 mg/100 ml and 30 – 80 mg/100kcal.
A23C 7/04 - Enlèvement du lait des substances indésirables
A23C 9/15 - Produits laitiers reconstitués ou recombinés ne contenant aucune graisse ou protéine autre que celles du lait
A23J 1/20 - Préparation des compositions à base de protéines pour l'alimentation; Ouverture des œufs par grandes quantités et séparation du jaune du blanc à partir du petit-lait
The invention relates to a process for dephosphorylation of skim milk, ultra-filtered milk (UF milk) or micellar casein isolate (MCI) comprising (i) acidification of a skim milk, UF milk or MCI preferably not lower than pH 6.0, preferably between 6.0 and 6.7, (ii) cooling the acidified skim milk, UF milk or MCI to the temperature between 0 °C and 15°C, (iii) adding gluconate and/or maleate to the cooled skim milk, UF milk or MCI and, (iv) washing the skim milk, UF milk or MCI, to remove phosphorus, thus dephosphorylating the skim milk, UF milk or MCI, preferably to an extent that the total phosphorous content of the skim milk, UF milk or MCI is reduced with at least 20%, preferably 20-40%, more preferably 30 - 40 % compared to the material provided to step (i). The invention also relates to dephosphorylated skim milk, UF milk or MCI obtainable by the process of the invention, and to a liquid heat-sterilized enteral nutritional composition comprising 2.0 - 3.0 kcal/ml wherein 16 - 35 en % is provided by protein, the combination of caloric content and relative protein caloric content selected such that there is 10 - 18 g/100 ml protein, preferably 12 - 18 g/100 ml protein in the composition, wherein the protein comprises micellar casein (MC), whey protein (WP) and optionally caseinate (CAS), wherein there is at least 70 wt % MC and less than 15 wt % WP, based on total protein content, and wherein the composition has a total amount of phosphorous less than 192 mg/100 ml and/or 30 - 80 mg/100kcal, preferably at least 30 - 80 mg/100 kcal, most preferably less than 192 mg/100 ml and 30 - 80 mg/100kcal.
A23C 7/04 - Enlèvement du lait des substances indésirables
A23C 9/15 - Produits laitiers reconstitués ou recombinés ne contenant aucune graisse ou protéine autre que celles du lait
A23J 1/20 - Préparation des compositions à base de protéines pour l'alimentation; Ouverture des œufs par grandes quantités et séparation du jaune du blanc à partir du petit-lait
The present invention concerns a powdered nutritional composition comprising dairy protein and plant-based protein with improved organoleptic properties and flowability, a dry-blending process for obtaining the nutritional composition and a method for providing nutrition to a subject comprising administering the nutritional composition. The nutritional compositions according to the invention have an improved flowability index and improved organoleptic properties.
A23C 9/18 - Lait sous la forme d'un produit comprimé sec ou semi-solide
A23C 11/06 - Succédanés du lait, p.ex. compositions pour remplacer le lait dans le café au lait contenant au moins un composé d'origine non laitière comme source de matières grasses ou de protéines contenant des protéines d'origine non laitière
A23L 33/00 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement
A23P 10/40 - Fabrication de poudres à écoulement libre ou instantanées, c. à. d. de poudres reconstituées rapidement par l’ajout d’un liquide
A23L 33/125 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
The present invention relates to a method of fortifying human nutrition with free amide containing amino acids, a method of providing infant nutrition to an infant of a lactating woman that suffers from allergy or of a lactating woman that has suffered from allergy, and supplements or fortified infant formulas comprising free L-glutamine and/or free L-asparagine for use in the treatment or prevention of allergy in infants of a lactating woman that suffers from allergy or of a lactating woman that has suffered from allergy.
A lid structure (10) for a container (40) comprises an annular collar (14) for attachment to the container, having an opening (15) for providing access to an interior (56) of the container. The lid structure further comprises a lid (12) for closing the opening, connected to the collar by a first living hinge. The lid comprises a first lid portion and a second lid portion connected together by a second living hinge which traverses the top surface of the lid and is parallel to the first living hinge. The first lid portion covers the opening. The second lid portion comprises a mating element and the collar comprises a complementary mating element, being configured to engage together to latch the lid to the collar in the closed position of the lid, whereby latching and unlatching of the lid structure is provided by a pivotable motion of the second lid portion about the second living hinge.
B65D 43/16 - Couvercles ou chapeaux inamovibles s'ouvrant à charnières vers le haut ou vers le bas
B65D 43/22 - Dispositifs servant à maintenir en position fermée, p.ex. colliers
B65D 55/16 - Dispositifs empêchant la perte des éléments de fermeture amovibles
17.
METHOD FOR EXPANDING A CYLINDRICAL METALLIC PRECURSOR IN THE MANUFACTURE OF A THREE-PIECE CAN AND SHAPING MANDREL FOR EXPANDING A CYLINDRICAL METALLIC PRECURSOR
A method is described for expanding a cylindrical metallic precursor in the manufacture of a three-piece can. The method comprises the steps of: arranging the precursor, having an initial diameter, around a shaping mandrel, the shaping mandrel having a plurality of longitudinally extending segments disposed radially about a longitudinal axis of the shaping mandrel, the segments having arcuate surfaces for engaging an inner surface of the precursor wall; actuating, in a first step, a first subgroup of the plurality of segments to expand outwards to engage with the inner surface of the precursor wall and expand at least a portion of it to a first diameter that is larger than the initial diameter of the precursor; and actuating, in a second step, a second subgroup of the plurality of segments to expand outwards and also engage with the inner surface of the precursor wall whereby the second subgroup expands at least a portion of the precursor to a second diameter that is larger than the first diameter. The method allows a greater degree of expansion of the wall of a cylindrical metallic container, whereby greater variations in diameter can be achieved between recessed portions and the remainder of the wall.
B21D 51/26 - Fabrication d'objets creux caractérisés par l'usage de l'objet de boîtes de conserve ou bidons; Fermeture des boîtes de conserve ou des bidons de façon définitive
B65D 8/00 - Réceptacles de section transversale courbe, dont le corps est formé par jonction ou liaison de plusieurs composants rigides, ou sensiblement rigides, constitués en totalité ou principalement en métal, en matière plastique, en bois ou en un matériau d
B65D 17/00 - Réceptacles rigides ou semi-rigides spécialement conçus pour être ouverts par coupage ou perçage, ou en perçant ou en déchirant des éléments ou des parties frangibles
METHOD FOR EXPANDING A CYLINDRICAL METALLIC PRECURSOR IN THE MANUFACTURE OF A THREE-PIECE CAN AND SHAPING MANDREL FOR EXPANDING A CYLINDRICAL METALLIC PRECURSOR
A method is described for expanding a cylindrical metallic precursor in the manufacture of a three-piece can. The method comprises the steps of: arranging the precursor, having an initial diameter, around a shaping mandrel, the shaping mandrel having a plurality of longitudinally extending segments disposed radially about a longitudinal axis of the shaping mandrel, the segments having arcuate surfaces for engaging an inner surface of the precursor wall; actuating, in a first step, a first subgroup of the plurality of segments to expand outwards to engage with the inner surface of the precursor wall and expand at least a portion of it to a first diameter that is larger than the initial diameter of the precursor; and actuating, in a second step, a second subgroup of the plurality of segments to expand outwards and also engage with the inner surface of the precursor wall whereby the second subgroup expands at least a portion of the precursor to a second diameter that is larger than the first diameter. The method allows a greater degree of expansion of the wall of a cylindrical metallic container, whereby greater variations in diameter can be achieved between recessed portions and the remainder of the wall.
B21D 51/26 - Fabrication d'objets creux caractérisés par l'usage de l'objet de boîtes de conserve ou bidons; Fermeture des boîtes de conserve ou des bidons de façon définitive
A lid structure (10) for a container (40) comprises an annular collar (14) for attachment to the container, having an opening (15) for providing access to an interior (56) of the container. The lid structure further comprises a lid (12) for closing the opening. The lid has an outer periphery (16) and an upper surface (18) with a circumferential ridge (20) located near to but spaced from the outer periphery, whereby a further container having a first base diameter (D1) can stack at an outside of the circumferential ridge. The circumferential ridge has at least two interruptions (22) dividing the circumferential ridge into at least two ridge portions (20A, B) whereby at least two further containers having the first base diameter can stack partially on the lid.
A lid structure (10) for a container (40) comprises an annular collar (14) for attachment to the container, having an opening (15) for providing access to an interior (56) of the container. The lid structure further comprises a lid (12) for closing the opening. The lid has an outer periphery (16) and an upper surface (18) with a circumferential ridge (20) located near to but spaced from the outer periphery, whereby a further container having a base diameter (dr) can stack at an outside of the circumferential ridge. The circumferential ridge has at least two interruptions (22) dividing the circumferential ridge into at least two ridge portions (20A, B) whereby at least two further containers having the same base diameter can stack partially on the lid.
The present invention concerns a powdered nutritional composition comprising intact protein and partially hydrolysed whey protein and a dry-blending process for obtaining the powdered nutritional composition.
A method performed by an electronic device assessing a first nutritional composition, obtaining (201, 301, 401) first visual information of the first nutritional composition; determining (202) whether there is a phase separation of the first nutritional composition based on the first visual information; if it is determined that there is a phase separation, determining (203) properties of at least one layer of the phase separation of the first nutritional composition based on the first visual information.
A23C 9/00 - Préparations à base de lait; Lait en poudre ou préparations à base de lait en poudre
A23C 13/00 - Crème; Préparations à base de crème; Leur fabrication
G01N 15/00 - Recherche de caractéristiques de particules; Recherche de la perméabilité, du volume des pores ou de l'aire superficielle effective de matériaux poreux
G01N 33/06 - Détermination de la teneur en graisses, p.ex. par le butyromètre
23.
Mix of specific Bifidobacterium species and specific non-digestible oligosaccharides
A consortium of specific probiotic bacteria comprising Bifidobacterium bifidum and Bifidobacterium breve with specific carbohydrate degrading properties, specific human milk oligosaccharide and preferably also beta-galacto-oligosaccharides with a higher degree of polymerization, is particularly effective for improving intestinal microbiota resilience.
A23L 33/135 - Bactéries ou leurs dérivés, p.ex. probiotiques
A23L 33/00 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement
A23L 33/125 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
24.
Solid composition suitable as a nutritional composition or supplement for animals that suffer from brain related disorders, decline or diseases
The invention pertains to a solid composition suitable for treating adult animals that suffer from brain-related disorders, brain-related decline or brain-related diseases, preferably suitable for treating adult animals that suffer from brain-related disorders, the composition containing (i) a uridine source, wherein the amount of the sum of all uridine sources, calculated on the basis of the weight of the molar equivalent of uridine monophosphate (UMP), is 0.3-15 g per 100 g dry weight of the composition, (ii) a polyunsaturated fatty acid, preferably an omega-3 polyunsaturated fatty acid, (iii) choline bitartrate, (iv) a buffering salt component, and (v) a milk protein source, wherein the milk protein source is a milk powder, and the buffering salt component containing at least one food approved salt, with a buffering capacity between pH 5-8, the buffering salt component preferably containing a mixture of food-approved salts, or a food-approved salt and its conjugated acid or base.
A61K 31/7072 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p.ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle contenant des pyrimidines condensées ou non-condensées ayant des groupes oxo liés directement au cycle pyrimidine, p.ex. cytidine, acide cytidylique ayant deux groupes oxo liés directement au cycle pyrimidine, p.ex. uridine, acide uridylique, thymidine, zidovudine
A61K 31/202 - Acides carboxyliques, p.ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p.ex. acides stéarique, palmitique ou arachidique ayant au moins trois doubles liaisons, p.ex. acide linolénique
The invention pertains to a liquid nutritional composition for use in prevention and/or treatment of whole body protein metabolism decline or whole body protein function decline, or for improving whole body protein metabolism or whole body protein function, particularly for use in muscle decline, or for improving muscle function, in a human subject suffering from metabolic stress and/or starvation, wherein the human subject is preferably a human elderly subject of at least 50 years of age, wherein the composition comprises a protein fraction comprising (a) 15 to 35 weight % of casein; (b) 25 to 50 weight % of whey protein; (c) 10 to 30 weight % of soy protein; and (d) 10 to 30 weight % of pea protein; relative to the total protein in the protein fraction, wherein the sum of said proteins preferably equals 100 weight % of the protein fraction.
Electronic device for estimating a height of a human, the electronic device comprising: a processor configured to: obtain an image including at least a part of a representation of the human and reference information; input the image to a first neural network and obtain as output from the first neural network first information, the first information related to a plurality of keypoints in the body of the human; input the image to a second neural network and obtain as output from the second neural network second information, the second information related to the reference information; and estimate the height of the human based on the first information and the second information; and an output unit configured to output the estimated height.
The invention concerns a process for preparing an ultrafiltered whey protein hydrolysate comprising tolerogenic peptides wherein an emulsifier and/or a chaotropic agent is added before ultrafiltration. The invention further concerns the product obtainable by the process.
A23C 9/142 - Préparations à base de lait; Lait en poudre ou préparations à base de lait en poudre dans lesquelles la composition chimique du lait est modifiée par des traitements non chimiques par dialyse, osmose inverse ou ultrafiltration
A23C 21/02 - Petit-lait; Préparations à base de petit-lait contenant des micro-organismes, ou des enzymes, ou traités à l'aide de ceux-ci
A23C 21/08 - Petit-lait; Préparations à base de petit-lait contenant d'autres additifs organiques, p.ex. des produits végétaux ou animaux
Provided herein is an enteral ketogenic composition comprising (i) a lipid fraction comprising 45 to 65 g lipids, (ii) a carbohydrate fraction comprising 5 to 12 g digestible carbohydrates, and (iii) a protein fraction comprising 15 - 25 g of protein per 100g of the ketogenic composition, having a ketogenic weight ratio between 1.5:1 and 3.0:1 and therapeutic uses thereof.
A23L 33/125 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
A23L 33/21 - Adjonction de substances essentiellement non digestibles, p.ex. de fibres diététiques
A23L 33/00 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement
A61K 31/202 - Acides carboxyliques, p.ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p.ex. acides stéarique, palmitique ou arachidique ayant au moins trois doubles liaisons, p.ex. acide linolénique
A61K 31/23 - Esters, p.ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p.ex. pravastatine d'acides ayant un groupe carboxyle lié à une chaîne d'au moins sept atomes de carbone
A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p.ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence
A61K 31/201 - Acides carboxyliques, p.ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p.ex. acides stéarique, palmitique ou arachidique ayant une ou deux doubles liaisons, p.ex. acides oléique ou linoléique
A61K 31/7004 - Monosaccharides ayant uniquement des atomes de carbone, d'hydrogène et d'oxygène
A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p.ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle
A61K 31/715 - Polysaccharides, c. à d. ayant plus de cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiques; Leurs dérivés, p.ex. éthers, esters
The present invention concerns nutritional compositions for infants and young children that are high in oleic acid and low in palmitic acid and comprise galacto-oligosaccharides, in particular including beta1,3′-galactosyllactose. The nutritional compositions are particularly advantageous for improving intestinal barrier function.
A61K 31/201 - Acides carboxyliques, p.ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p.ex. acides stéarique, palmitique ou arachidique ayant une ou deux doubles liaisons, p.ex. acides oléique ou linoléique
A61P 1/00 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif
29 - Viande, produits laitiers et aliments préparés ou conservés
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Milk and milk products; yogurt; milk substitutes; plant-based milk and milk products, namely milks derived from plants, vegetables, grains, nuts, seeds, beans and fruits; cottage cheese; milk beverages, milk predominating; compotes; fruit-based snack foods; nut-based snack bars; seed-based snack bars; probiotic dairy-based snack bar; powdered milk; frozen, prepared, dried, preserved or packaged meals consisting primarily of meat, fish, poultry, ham, vegetables and game; yogurt-based snack foods; fruit purees Food for special medical purposes; dietetic foods and substances adapted for medical purposes; food for babies; food for patients and sick persons; infant formula; food for babies with special nutritional needs; non-dairy and plant-based milks for babies, namely milks derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits; nutritional products for medical purposes; nutritional supplements; cereals for infants; vitamin preparations; dietetic foods for pregnant, lactating and breast feeding women; dietetic milk for pregnant, lactating and breast feeding women; dietary fiber; protein dietary supplements; soy protein dietary supplements; protein supplements shakes; energy bars used as food supplements; dietary supplements for human beings
31.
NUTRITIONAL COMPOSITION FOR MUSCLE MASS, STRENGTH AND FUNCTION
The invention pertains to a nutritional composition for use in prevention and/or treatment of whole body protein metabolism decline or whole body protein function decline, or for therapeutic use in improving whole body protein metabolism or whole body protein function, in a human subject, wherein the human subject is preferably an ageing human elderly subject of at least 40 years of age, wherein the composition comprises a protein fraction comprising 32-58 wt % pea protein, 30-56 wt % soy protein and 8-16 wt % free leucine, preferably a protein fraction comprising 36-54 wt % pea protein, 34-52 wt % soy protein and 10-14 wt % free leucine, and optionally up to 5 wt % of free branched chain amino acids other than leucine, based on all proteinaceous matter, wherein the composition is essentially free from animal protein.
The present invention relates to a use of octenylsuccinyl anhydride substituted starch (OSA starch) for increasing the dry weight content and/or the fat content of a liquid composition that is subjected to a spray-drying step, and also to a process for preparing powders. The present invention enables the spray-drying of emulsions that contain a high amount of fat. The present invention also relates to the powder products obtainable by the process and nutritional products such as an infant milk powder, grow up milk, toddler milk or as a medical nutritional product that can be formulated therewith.
A23L 33/115 - Acides gras ou leurs dérivés; Graisses ou huiles
A23L 29/219 - Amidon chimiquement modifié; Produits de réaction ou de complexation de l’amidon avec d’autres produits chimiques
A23L 33/00 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement
A23L 33/125 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
A23P 10/47 - Fabrication de poudres à écoulement libre ou instantanées, c. à. d. de poudres reconstituées rapidement par l’ajout d’un liquide utilisant des additifs, p.ex. des émulsifiants, des agents mouillants ou des agents liant la poussière
A61K 31/202 - Acides carboxyliques, p.ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p.ex. acides stéarique, palmitique ou arachidique ayant au moins trois doubles liaisons, p.ex. acide linolénique
A61K 47/36 - Polysaccharides; Leurs dérivés, p.ex. gommes, amidon, alginate, dextrine, acide hyaluronique, chitosane, inuline, agar-agar ou pectine
A61K 47/44 - Huiles, graisses ou cires couvertes par plus d’un des groupes ; Huiles, graisses ou cires naturelles ou naturelles modifiées, p.ex. huile de ricin, huile de ricin polyéthoxylée, cire de lignite, lignite, gomme-laque, colophane, cire d’abeille ou lanoline
33.
NUTRITIONAL COMPOSITION WITH IMPROVED SEGREGATION RESISTANCE
The present invention relates to a powdered nutritional composition comprising (i) milk formula particles comprising lipid, protein, digestible carbohydrates, and (ii) human milk oligosaccharide (HMO) particles, wherein the nutritional composition is selected from an infant, follow-on formula and growing up milk, wherein said nutritional composition is not human milk and wherein the lipid in the milk formula particles is in the form of lipid globules, and a. the lipid globules have a mode diameter based on volume of at least 1 μm, and/or b. at least 40 vol.% of the lipid globules have a diameter of 2 to 12 μm and wherein the HMO particles comprise at least 2'fucosyllactose (2'FL). The invention also relates to a process to prepare the composition and uses thereof.
A23L 33/21 - Adjonction de substances essentiellement non digestibles, p.ex. de fibres diététiques
A23L 33/00 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement
A61K 31/702 - Oligosaccharides, c. à. d. ayant trois à cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiques
A61P 1/00 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif
A61K 31/201 - Acides carboxyliques, p.ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p.ex. acides stéarique, palmitique ou arachidique ayant une ou deux doubles liaisons, p.ex. acides oléique ou linoléique
A61K 31/202 - Acides carboxyliques, p.ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p.ex. acides stéarique, palmitique ou arachidique ayant au moins trois doubles liaisons, p.ex. acide linolénique
A61K 31/23 - Esters, p.ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p.ex. pravastatine d'acides ayant un groupe carboxyle lié à une chaîne d'au moins sept atomes de carbone
A61K 31/20 - Acides carboxyliques, p.ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p.ex. acides stéarique, palmitique ou arachidique
A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p.ex. composés antiphlogistiques et pour le cœur
The present invention concerns nutritional compositions comprising a mixture of non-digestible oligosaccharides consisting of a combination of 5 specific human milk oligosaccharides, beta-galacto-oligosaccharides and long chain fructo-oligosaccharides (IcFOS). The nutritional compositions are of benefit for improving intestinal microbiota.
The present invention relates to nutritional compositions comprising non-digestible oligosaccharides and beta-casein comprising at least 75% by weight of a beta-casein variant having a proline at position 67 of the beta-casein amino acid sequence for use in improving gut microbiota of an infant or child, wherein improvement of gut microbiota encompasses increasing Lactobacillus levels. Advantageously, the composition further favors the increase of Bifidobacterium levels and inhibits the growth of opportunistic and/or pathogenic bacteria.
A nutritional composition comprising digestible carbohydrates, protein and lipid, wherein the lipid is in the form of lipid globules which are at least partly coated on the surface with phospholipids, for improving the gut microbiota and reducing opportunistic pathogens in the gut of human infants.
The present invention relates to the field of infant nutrition. Particularly, the present invention relates to infant formula comprising human milk oligosaccharides wherein the infant formula is specific for infants aged 0-36 months at different lactation stages. The invention also relates to lactation stage specific systems and methods of providing nutrition to an infant.
A23L 33/125 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
A23C 9/20 - Produits diététiques à base de lait non couverts par les groupes
A23L 33/00 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement
38.
INFANT FORMULA FOR FEEDING INFANTS RECEIVING INFANT FORMULA AND HUMAN BREAST MILK
The present invention relates to infant formula suitable for feeding infants who receive both infant formula and human breast milk (mixed milk fed infants).
A23L 33/125 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
A23L 33/00 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement
39.
INFANT FORMULA FOR IMPROVING COGNITIVE DEVELOPMENT
A nutritional composition comprising digestible carbohydrates, protein and lipid, wherein the lipid is in the form of lipid globules which are at least partly coated on the surface with phospholipids, for increasing myelination in the brain of an infant who has delayed brain development or is at risk of having delayed brain development.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
29 - Viande, produits laitiers et aliments préparés ou conservés
30 - Aliments de base, thé, café, pâtisseries et confiseries
Produits et services
(1) Food for special medical purposes; dietetic foods and substances adapted for medical purposes; food for babies; food for patients and sick persons; infant formula; food for babies with special nutritional needs; non-dairy and plant-based milks for babies, namely milks derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits; nutritional products for medical purposes; nutritional supplements; cereals for infants; vitamin preparations; dietetic foods for pregnant, lactating and breast feeding women; dietetic milk for pregnant, lactating and breast feeding women; dietary fiber; protein dietary supplements; soy protein dietary supplements; protein supplements shakes; energy bars used as food supplements; dietary supplements for human beings.
(2) Milk and milk products; yogurt; milk substitutes; plant-based milk and milk products, namely milks derived from plants, vegetables, grains, nuts, seeds, beans and fruits; cottage cheese; milk beverages, milk predominating; compotes; fruit-based snack foods; nut-based snack bars; seed-based snack bars; probiotic dairy-based snack bar; powdered milk; frozen, prepared, dried, preserved or packaged meals consisting primarily of meat, fish, poultry, ham, vegetables and game; yogurt-based snack foods; fruit purees.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
29 - Viande, produits laitiers et aliments préparés ou conservés
30 - Aliments de base, thé, café, pâtisseries et confiseries
Produits et services
(1) Food for special medical purposes; dietetic foods and substances adapted for medical purposes; food for babies; food for patients and sick persons; infant formula; food for babies with special nutritional needs; non-dairy and plant-based milks for babies, namely milks derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits; nutritional products for medical purposes; nutritional supplements; cereals for infants; vitamin preparations; dietetic foods for pregnant, lactating and breast feeding women; dietetic milk for pregnant, lactating and breast feeding women; dietary fiber; protein dietary supplements; soy protein dietary supplements; protein supplements shakes; energy bars used as food supplements; dietary supplements for human beings.
(2) Milk and milk products; yogurt; milk substitutes; plant-based milk and milk products, namely milks derived from plants, vegetables, grains, nuts, seeds, beans and fruits; cottage cheese; milk beverages, milk predominating; compotes; fruit-based snack foods; nut-based snack bars; seed-based snack bars; probiotic dairy-based snack bar; powdered milk; frozen, prepared, dried, preserved or packaged meals consisting primarily of meat, fish, poultry, ham, vegetables and game; yogurt-based snack foods; fruit purees.
42.
NUTRITIONAL COMPOSITION FOR IMPROVING CELL MEMBRANES
An early in life nutritional intervention with a lipid component having both large lipid globules with phospholipids and an increased amount of palmitic acid in the sn-2 position in triglycerides were found to improve the fatty acid composition of cell membranes, in particular brain membranes.
A61K 31/201 - Acides carboxyliques, p.ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p.ex. acides stéarique, palmitique ou arachidique ayant une ou deux doubles liaisons, p.ex. acides oléique ou linoléique
A23L 33/00 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement
A61K 31/202 - Acides carboxyliques, p.ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p.ex. acides stéarique, palmitique ou arachidique ayant au moins trois doubles liaisons, p.ex. acide linolénique
A61K 31/688 - Diesters d'acide du phosphore avec deux composés hydroxyle, p.ex. phosphatidylinositols les deux composés hydroxylés ayant des atomes d'azote, p.ex. sphingomyélines
A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
29 - Viande, produits laitiers et aliments préparés ou conservés
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Milk and milk products; yogurt; milk substitutes; plant-based milk and milk products, namely milks derived from plants, vegetables, grains, nuts, seeds, beans and fruits; cottage cheese; milk beverages, milk predominating; compotes; fruit-based snack foods; nut-based snack bars; seed-based snack bars; probiotic dairy-based snack bar; powdered milk; frozen, prepared, dried, preserved or packaged meals consisting primarily of meat, fish, poultry, ham, vegetables and game; yogurt-based snack foods; fruit purees Food for special medical purposes; dietetic foods and substances adapted for medical purposes; food for babies; food for patients and sick persons; infant formula; food for babies with special nutritional needs; non-dairy and plant-based milks for babies, namely milks derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits; nutritional products for medical purposes; nutritional supplements; cereals for infants; vitamin preparations; dietetic foods for pregnant, lactating and breast feeding women; dietetic milk for pregnant, lactating and breast feeding women; dietary fiber; protein dietary supplements; soy protein dietary supplements; protein supplements shakes; energy bars used as food supplements; dietary supplements for human beings
NUTRICIA EARLY LIFE NUTRITION (SHANGHAI) CO., LTD (Chine)
Inventeur(s)
Renes, Ingrid Brunhilde
Thomassen, Gabriel
Knol, Jan
Ludwig, Thomas
Jin, Haofang
Abrégé
The present invention relates to compositions comprising lutein, non-digestible carbohydrates and at least one of casein phosphopetides or 1,3-dioleoyl-2-palmitoylglycerol.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Food for special medical purposes; dietetic foods and substances adapted for medical purposes; food for babies; food for patients and sick persons; infant formula; food for babies with special nutritional needs; non-dairy and plant-based milks for babies, namely milks derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits; nutritional products for medical purposes; nutritional supplements; cereals for infants; vitamin preparations; dietetic foods for pregnant, lactating and breast feeding women; dietetic milk for pregnant, lactating and breast feeding women; dietary fiber; protein dietary supplements; soy protein dietary supplements; protein supplements shakes; energy bars used as food supplements; dietary supplements for human beings
46.
METHOD FOR SUPPORTING MEMORY FUNCTION AND/OR COGNITIVE FUNCTION
The invention pertains to the use of therapeutically effective amounts of (a) (i) vitamin C and/or selenium and (ii) at least one of docosahexaenoic acid (22:6; DHA), eicosapentaenoic acid (20:5; EPA) and docosapentaenoic acid (22:5; DPA), or esters thereof; or (b) (i) vitamin C and/or selenium and (iii) one or more of uridine and cytidine, or salts, phosphates, acyl derivatives or esters thereof; or (c) a combination of (i), (ii) and (iii); wherein (a), (b) or (c) optionally further comprises vitamin E, in the manufacture of a product for therapeutically improving synaptic connectivity and/or therapeutically supporting memory and/or cognitive function in a human subject in need thereof.
A61K 31/202 - Acides carboxyliques, p.ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p.ex. acides stéarique, palmitique ou arachidique ayant au moins trois doubles liaisons, p.ex. acide linolénique
A61K 31/375 - Acide ascorbique, c. à d. vitamine C; Ses sels
A61K 31/7068 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p.ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle contenant des pyrimidines condensées ou non-condensées ayant des groupes oxo liés directement au cycle pyrimidine, p.ex. cytidine, acide cytidylique
A61K 31/7072 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p.ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle contenant des pyrimidines condensées ou non-condensées ayant des groupes oxo liés directement au cycle pyrimidine, p.ex. cytidine, acide cytidylique ayant deux groupes oxo liés directement au cycle pyrimidine, p.ex. uridine, acide uridylique, thymidine, zidovudine
29 - Viande, produits laitiers et aliments préparés ou conservés
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Milk and milk products; yogurt; milk substitutes; plant-based milk and milk products, namely milks derived from plants, vegetables, grains, nuts, seeds, beans and fruits; cottage cheese; milk beverages, milk predominating; compotes; fruit-based snack foods; nut-based snack bars; seed-based snack bars; probiotic dairy-based snack bar; powdered milk; frozen, prepared, dried, preserved or packaged meals consisting primarily of meat, fish, poultry, ham, vegetables and game; yogurt-based snack foods; fruit purees Food for special medical purposes; dietetic foods and substances adapted for medical purposes; food for babies; food for patients and sick persons; infant formula; food for babies with special nutritional needs; non-dairy and plant-based milks for babies, namely milks derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits; nutritional products for medical purposes; nutritional supplements; cereals for infants; vitamin preparations; dietetic foods for pregnant, lactating and breast feeding women; dietetic milk for pregnant, lactating and breast feeding women; dietary fiber; protein dietary supplements; soy protein dietary supplements; protein supplements shakes; energy bars used as food supplements; dietary supplements for human beings
The invention concerns formula for based on extensively hydrolysed protein and/or free amino acids for allergic infants that are thickened with a combination of xanthan gum and locust bean gum.
A23L 29/238 - Aliments ou produits alimentaires contenant des additifs; Leur préparation ou leur traitement contenant des agents gélifiants ou épaississants d'origine végétale à partir de graines, p.ex. gomme de caroube ou gomme de guar
A23L 29/269 - Aliments ou produits alimentaires contenant des additifs; Leur préparation ou leur traitement contenant des agents gélifiants ou épaississants d'origine microbienne, p.ex. xanthane ou dextrane
A23L 33/00 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement
A61P 1/04 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des ulcères, des gastrites ou des œsophagites par reflux, p.ex. antiacides, antisécrétoires, protecteurs de la muqueuse
A23L 33/125 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
The invention is in the field of thickened formulas for infants that suffer from regurgitation. In particular the infant formulas are thickened with a combination of xanthan gum and locust bean gum and comprise a mixture of specific nondigestible oligosaccharides.
A23L 33/125 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
A23L 29/238 - Aliments ou produits alimentaires contenant des additifs; Leur préparation ou leur traitement contenant des agents gélifiants ou épaississants d'origine végétale à partir de graines, p.ex. gomme de caroube ou gomme de guar
A23L 29/269 - Aliments ou produits alimentaires contenant des additifs; Leur préparation ou leur traitement contenant des agents gélifiants ou épaississants d'origine microbienne, p.ex. xanthane ou dextrane
A23L 33/00 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement
A61P 1/04 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des ulcères, des gastrites ou des œsophagites par reflux, p.ex. antiacides, antisécrétoires, protecteurs de la muqueuse
The invention concerns formula for based on extensively hydrolysed protein and/or free amino acids for allergic infants that are thickened with a combination of xanthan gum and locust bean gum.
A23L 29/238 - Aliments ou produits alimentaires contenant des additifs; Leur préparation ou leur traitement contenant des agents gélifiants ou épaississants d'origine végétale à partir de graines, p.ex. gomme de caroube ou gomme de guar
A23L 29/269 - Aliments ou produits alimentaires contenant des additifs; Leur préparation ou leur traitement contenant des agents gélifiants ou épaississants d'origine microbienne, p.ex. xanthane ou dextrane
A23L 33/00 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement
A61P 1/04 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des ulcères, des gastrites ou des œsophagites par reflux, p.ex. antiacides, antisécrétoires, protecteurs de la muqueuse
A23L 33/125 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
A card-based package for sensitive food products, comprises a container portion defining an interior space with a base and a sidewall extending to an upper peripheral edge for receiving a removable seal for hermetically sealing the container portion prior to use. The package further comprises a lid structure, that can open and close to allow selective access to the interior space after removal of the seal. The container portion and the lid structure are both formed of card-based material and at least the container portion has light, oxygen, and water vapour barrier properties sufficient for storage of the product for a period exceeding 24 months.
B65D 3/22 - Réceptacles rigides ou semi-rigides ayant un corps ou des parois périphériques de section transversale courbe ou partiellement courbe, réalisés en enroulant ou courbant du papier sans plier selon des lignes définies avec des parois faites en matériau stratifié
B65D 43/16 - Couvercles ou chapeaux inamovibles s'ouvrant à charnières vers le haut ou vers le bas
A closure for an infant formula package is disclosed. The package may comprise a container having an access opening to an interior space, for receiving the infant formula. The closure is arranged for selectively closing the access opening and comprises a lid and a scoop holder located on an underside of the lid, wherein both the lid and the scoop holder are formed of card-based material.
A closure for an infant formula package is disclosed. The package may comprise a container having an access opening to an interior space, for receiving the infant formula. The closure is arranged for selectively closing the access opening and comprises a lid and a scoop holder located on an underside of the lid to retain a scoop, wherein the scoop holder comprises an apertured plate having an apertured portion with an aperture therethrough to receive at least part of the scoop, and wherein both the lid and the scoop holder are formed of card-based material.
A card-based package for powdered infant nutrition is described. The package comprises a container portion having an access opening to an interior space for receiving the powered infant nutrition and a closure arranged for selectively closing the access opening. The closure comprises a collar portion connected to the container portion, a lid portion pivotably connected to the collar portion and a locking arrangement for selectively engaging said lid portion to said collar portion. The container portion, the lid portion, the collar portion and the locking arrangement are all formed from card-based material. The locking arrangement comprises a first locking element arranged on the collar portion and a second locking element arranged on the lid portion wherein the first locking element and the second locking element are arranged to engage together to prevent the lid portion from being opened. One of the first or second locking elements is actionable by a user to disengage the other locking element and unlock the lid portion.
B65D 43/16 - Couvercles ou chapeaux inamovibles s'ouvrant à charnières vers le haut ou vers le bas
B65D 3/26 - Dispositifs d'ouverture incorporés dans ou fixés aux réceptacles
B65D 6/00 - Réceptacles dont le corps est formé par jonction ou liaison de plusieurs composants rigides ou sensiblement rigides, constitués en totalité ou principalement en métal, en matière plastique, en bois ou en un matériau de remplacement
B65D 21/02 - Réceptacles de forme spéciale ou pourvus de garnitures ou de pièces de fixation, pour faciliter l'emboîtement, le gerbage ou l'assemblage
B65D 51/20 - Capuchons, couvercles ou chapeaux fonctionnant avec une fermeture intérieure disposée pour être ouverte en perçant, coupant ou déchirant
B65D 77/24 - Garnitures ou accessoires ajoutés ou incorporés durant le remplissage des réceptacles
55.
CARD BASED PACKAGE FOR POWDERED INFANT NUTRITION PRODUCTS
A card-based package for powdered infant nutrition, comprises a container portion, the container portion defining an interior space for receiving the powdered infant nutrition and having a base and a sidewall extending to an upper peripheral edge for receiving a removable seal for hermetically sealing the container portion prior to use. The package further comprises a collar portion and a lid portion. The collar portion is connected to and extends upwardly from the upper peripheral edge of the container portion and comprises a connection segment and an upper peripheral closure rim surrounding an access opening giving access to the interior space. The lid portion comprises a lid and a frame and forms a re-closable joint with the upper peripheral closure rim of the collar portion, allowing repeated and selective opening and closing of the access opening. The container portion, the collar portion and the lid portion all comprise card-based material.
B65D 3/26 - Dispositifs d'ouverture incorporés dans ou fixés aux réceptacles
B65D 6/00 - Réceptacles dont le corps est formé par jonction ou liaison de plusieurs composants rigides ou sensiblement rigides, constitués en totalité ou principalement en métal, en matière plastique, en bois ou en un matériau de remplacement
B65D 21/02 - Réceptacles de forme spéciale ou pourvus de garnitures ou de pièces de fixation, pour faciliter l'emboîtement, le gerbage ou l'assemblage
B65D 43/16 - Couvercles ou chapeaux inamovibles s'ouvrant à charnières vers le haut ou vers le bas
B65D 51/20 - Capuchons, couvercles ou chapeaux fonctionnant avec une fermeture intérieure disposée pour être ouverte en perçant, coupant ou déchirant
B65D 77/24 - Garnitures ou accessoires ajoutés ou incorporés durant le remplissage des réceptacles
05 - Produits pharmaceutiques, vétérinaires et hygièniques
41 - Éducation, divertissements, activités sportives et culturelles
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.
Produits et services
Food for special medical purposes; dietetic foods and
substances adapted for medical purposes; food for babies;
dietic food adapted for invalids; infant formula; food for
babies with special nutritional needs; non-dairy and
plant-based milks for babies, namely milks derived from
plants, vegetables, cereals, grains, nuts, seeds, beans and
fruits; nutritional products for medical purposes;
nutritional supplements; cereals for infants; vitamin
preparations; dietetic foods for pregnant, lactating and
breast feeding women; dietetic milk for pregnant, lactating
and breast feeding women; dietary fiber; protein dietary
supplements; soy protein dietary supplements; protein
supplements shakes; energy bars used as food supplements;
dietary supplements for human beings. Provision of training and information about it, in the
fields of preconception, pregnancy, birth, motherhood, baby
care, parenting and nutrition, for parents, mothers and
future parents, also via on-line connections; arranging,
organizing and conducting educational seminars and
conferences, including as provided by means of the internet,
in the fields of baby nutrition, food and drink, including
dietetic food and drink and food and drink adapted for
medical use, as well as in the fields of health, parenting,
personal hygiene, pregnancy, body and beauty care for
babies, infants and pregnant, lactating and breast feeding
women. Provision of advisory services and information in the field
of health care, nutrition and on hygienic and beauty care
for human beings, including advisory and information
services in relation to issues about preconception,
pregnancy, birth, motherhood, baby care and parenting, for
parents, mothers and future parents, also via on-line
connections; medical services; advisory, consultancy and
information services, including as provided by means of the
internet, in the fields of medicine, health care, baby
nutrition, personal hygiene, body and beauty care for babies
and infants, lactating and breast feeding women.
57.
CARD BASED PACKAGE FOR POWDERED INFANT NUTRITION PRODUCTS
A card-based package for powdered infant nutrition, comprises a container portion, the container portion defining an interior space for receiving the powdered infant nutrition and having a base and a sidewall extending to an upper peripheral edge for receiving a removable seal for hermetically sealing the container portion prior to use. The package further comprises a collar portion and a lid portion. The collar portion is connected to and extends upwardly from the upper peripheral edge of the container portion and comprises a connection segment and an upper peripheral closure rim surrounding an access opening giving access to the interior space. The lid portion comprises a lid and a frame and forms a re-closable joint with the upper peripheral closure rim of the collar portion, allowing repeated and selective opening and closing of the access opening. The container portion, the collar portion and the lid portion all comprise card-based material.
B65D 3/26 - Dispositifs d'ouverture incorporés dans ou fixés aux réceptacles
B65D 6/00 - Réceptacles dont le corps est formé par jonction ou liaison de plusieurs composants rigides ou sensiblement rigides, constitués en totalité ou principalement en métal, en matière plastique, en bois ou en un matériau de remplacement
B65D 21/02 - Réceptacles de forme spéciale ou pourvus de garnitures ou de pièces de fixation, pour faciliter l'emboîtement, le gerbage ou l'assemblage
B65D 43/16 - Couvercles ou chapeaux inamovibles s'ouvrant à charnières vers le haut ou vers le bas
B65D 51/20 - Capuchons, couvercles ou chapeaux fonctionnant avec une fermeture intérieure disposée pour être ouverte en perçant, coupant ou déchirant
B65D 77/24 - Garnitures ou accessoires ajoutés ou incorporés durant le remplissage des réceptacles
A card-based package for powdered infant nutrition is described. The package comprises a container portion having an access opening to an interior space for receiving the powered infant nutrition and a closure arranged for selectively closing the access opening. The closure comprises a collar portion connected to the container portion, a lid portion pivotably connected to the collar portion and a locking arrangement for selectively engaging said lid portion to said collar portion. The container portion, the lid portion, the collar portion and the locking arrangement are all formed from card-based material. The locking arrangement comprises a first locking element arranged on the collar portion and a second locking element arranged on the lid portion wherein the first locking element and the second locking element are arranged to engage together to prevent the lid portion from being opened. One of the first or second locking elements is actionable by a user to disengage the other locking element and unlock the lid portion.
B65D 43/16 - Couvercles ou chapeaux inamovibles s'ouvrant à charnières vers le haut ou vers le bas
B65D 3/26 - Dispositifs d'ouverture incorporés dans ou fixés aux réceptacles
B65D 6/00 - Réceptacles dont le corps est formé par jonction ou liaison de plusieurs composants rigides ou sensiblement rigides, constitués en totalité ou principalement en métal, en matière plastique, en bois ou en un matériau de remplacement
B65D 21/02 - Réceptacles de forme spéciale ou pourvus de garnitures ou de pièces de fixation, pour faciliter l'emboîtement, le gerbage ou l'assemblage
B65D 51/20 - Capuchons, couvercles ou chapeaux fonctionnant avec une fermeture intérieure disposée pour être ouverte en perçant, coupant ou déchirant
B65D 77/24 - Garnitures ou accessoires ajoutés ou incorporés durant le remplissage des réceptacles
A card-based package for sensitive food products, comprises a container portion defining an interior space with a base and a sidewall extending to an upper peripheral edge for receiving a removable seal for hermetically sealing the container portion prior to use. The package further comprises a lid structure, that can open and close to allow selective access to the interior space after removal of the seal. The container portion and the lid structure are both formed of card-based material and at least the container portion has light, oxygen, and water vapour barrier properties sufficient for storage of the product for a period exceeding 24 months.
B65D 3/22 - Réceptacles rigides ou semi-rigides ayant un corps ou des parois périphériques de section transversale courbe ou partiellement courbe, réalisés en enroulant ou courbant du papier sans plier selon des lignes définies avec des parois faites en matériau stratifié
B65D 43/16 - Couvercles ou chapeaux inamovibles s'ouvrant à charnières vers le haut ou vers le bas
60.
A PROCESS OF PREPARING AN ENTERAL NUTRITIONAL COMPOSITION
A process of preparing a shelf-stable liquid enteral nutritional composition, said process comprising the steps of providing an oil-in-water emulsion, sterilizing the emulsion by direct steam injection (DSI) to obtain a sterilized emulsion with a F0 value of at least 3 and subjecting the sterilized emulsion to high pressure homogenization.
A23L 3/3409 - Conservation des aliments ou produits alimentaires, en général, p.ex. pasteurisation ou stérilisation, spécialement adaptée aux aliments ou produits alimentaires par traitement au moyen de produits chimiques sous forme de gaz, p.ex. fumigation; Compositions ou appareils à cet effet
A23L 5/30 - Traitement physique, p.ex. par des moyens électriques ou magnétiques, par énergie ondulatoire ou par irradiation
A23C 9/20 - Produits diététiques à base de lait non couverts par les groupes
A23L 33/00 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement
A23C 11/00 - Succédanés du lait, p.ex. compositions pour remplacer le lait dans le café au lait
A23L 33/00 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement
A23L 33/115 - Acides gras ou leurs dérivés; Graisses ou huiles
A23L 33/125 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
A23L 33/135 - Bactéries ou leurs dérivés, p.ex. probiotiques
NUTRICIA EARLY LIFE NUTRITION (SHANGHAI) CO., LTD. (Chine)
Inventeur(s)
Ward, Gregg
Liu, Mengjin
Guo, Bingzhi
Jin, Yi
Zheng, Yixiao
Hu, Jinhui
Foussat, Agathe Camille
Song, Jiahang
Ludwig, Thomas
Abrégé
A computer-implemented method of analyzing excreta, comprising: obtaining visual information of excreta, providing the visual information to an artificial intelligence (AI) model; processing the visual information using the AI model to determine a plurality of scales of the excreta; outputting the plurality of scales of the excreta, receiving at least one input to adjust the plurality of scales of the excreta, and providing suggestion based on the adjusted plurality of scales of the excreta.
A23L 33/125 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
63.
NUTRITION DIGESTIVE EFFICACY ASSISTANT AND COMPUTER IMPLEMENTED ALGORITHM THEREOF
NUTRICIA EARLY LIFE NUTRITION (SHANGHAI) CO., LTD. (Chine)
Inventeur(s)
Ward, Gregg
Liu, Mengjin
Guo, Bingzhi
Jin, Yi
Zheng, Yixiao
Hu, Jinhui
Foussat, Agathe Camille
Song, Jiahang
Ludwig, Thomas
Abrégé
A computer-implemented method of analyzing excreta, comprising: obtaining visual information of excreta, providing the visual information to an artificial intelligence (AI) model; processing the visual information using the AI model to determine a plurality of scales of the excreta; outputting the plurality of scales of the excreta, receiving at least one input to adjust the plurality of scales of the excreta, and providing suggestion based on the adjusted plurality of scales of the excreta.
A23L 33/00 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement
A23L 33/115 - Acides gras ou leurs dérivés; Graisses ou huiles
A23L 33/125 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
A23L 33/135 - Bactéries ou leurs dérivés, p.ex. probiotiques
The invention pertains to a fiber mixture comprising arabinoxylan, beta-glucan, pectin, and resistant starch, nutritional compositions comprising the fiber mixture and uses thereof. The fiber mixture comprising is beneficially used in improving intestinal health and/or preventing impaired intestinal health.
A23L 29/00 - Aliments ou produits alimentaires contenant des additifs; Leur préparation ou leur traitement
A23L 29/206 - Aliments ou produits alimentaires contenant des additifs; Leur préparation ou leur traitement contenant des agents gélifiants ou épaississants d'origine végétale
A carrier for transport and administration of enteral food or other liquids comprises a shell, having a bottom tray, a back plate and two side plates and a front plate for attachment of a feed pump. Support elements are provided for holding a container in place within the shell. The support elements are height adjustable with respect to the bottom tray, thereby allowing a container to be supported at different positions above the bottom tray. The front plate is detachable from the shell and can be used as a stand for the feed pump. The carrier can be easily integrated into a backpack or the like.
A61J 1/14 - Récipients spécialement adaptés à des fins médicales ou pharmaceutiques - Détails; Accessoires à cet effet
A61J 7/00 - Dispositifs pour administrer les médicaments par voie buccale, p.ex. cuillères; Dispositifs pour compter les pilules; Dispositions pour l'indication ou le rappel du moment où l'on doit prendre des médicaments
A61J 15/00 - Tubes pour l'alimentation thérapeutique
A45C 11/00 - Récipients pour articles non prévus dans les groupes
A45C 13/02 - Garnitures intérieures; Moyens pour retenir ou envelopper les objets
A carrier for transport and administration of enteral food or other liquids comprises a shell, having a bottom tray, a back plate and two side plates and a front plate for attachment of a feed pump. Support elements are provided for holding a container in place within the shell. The support elements are height adjustable with respect to the bottom tray, thereby allowing a container to be supported at different positions above the bottom tray. The front plate is detachable from the shell and can be used as a stand for the feed pump. The carrier can be easily integrated into a backpack or the like.
A61J 1/14 - Récipients spécialement adaptés à des fins médicales ou pharmaceutiques - Détails; Accessoires à cet effet
A61J 7/00 - Dispositifs pour administrer les médicaments par voie buccale, p.ex. cuillères; Dispositifs pour compter les pilules; Dispositions pour l'indication ou le rappel du moment où l'on doit prendre des médicaments
A61J 15/00 - Tubes pour l'alimentation thérapeutique
A45C 11/00 - Récipients pour articles non prévus dans les groupes
A45C 13/02 - Garnitures intérieures; Moyens pour retenir ou envelopper les objets
The invention relates to a fibre mixture comprising beta-galactooligosaccharides, inulin, resistant starch and soluble soy polysaccharides and to nutritional compositions comprising such a fibre mixture. The intended use of the fibre mixture and nutritional compositions is for preventing or treating constipation, especially in young children.
A23L 33/00 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement
A23L 33/21 - Adjonction de substances essentiellement non digestibles, p.ex. de fibres diététiques
A61K 31/702 - Oligosaccharides, c. à. d. ayant trois à cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiques
A61K 31/715 - Polysaccharides, c. à d. ayant plus de cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiques; Leurs dérivés, p.ex. éthers, esters
A61K 31/718 - Amidon ou amidon dégradé, p.ex. amylose, amylopectine
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61K 47/42 - Protéines; Polypeptides; Leurs produits de dégradation; Leurs dérivés p.ex. albumine, gélatine ou zéine
The present invention provides a process of producing a lactose concentrate, said process comprising the step of subjecting a partially demineralised aqueous lactose isolate to electrodialysis to produce a biotin-reduced lactose isolate containing at least 90% lactose by weight of dry matter and less than 2 mg ash per gram of lactose, and containing:
0.02-1.5 mg sodium per gram of lactose;
0.02-2 mg potassium per gram of lactose;
0.05-1.5 mg chloride per gram of lactose;
0.01-0.25 μg biotin per gram of lactose.
The present invention provides a process of producing a lactose concentrate, said process comprising the step of subjecting a partially demineralised aqueous lactose isolate to electrodialysis to produce a biotin-reduced lactose isolate containing at least 90% lactose by weight of dry matter and less than 2 mg ash per gram of lactose, and containing:
0.02-1.5 mg sodium per gram of lactose;
0.02-2 mg potassium per gram of lactose;
0.05-1.5 mg chloride per gram of lactose;
0.01-0.25 μg biotin per gram of lactose.
The present invention also relates to a demineralised lactose concentrate having a reduced biotin content that can be produced by the aforementioned process. The invention further relates to an oligosaccharide-enriched biotin-reduced fraction that is obtained when lactose is separated before or after the electrodialysis step.
A23C 9/144 - Préparations à base de lait; Lait en poudre ou préparations à base de lait en poudre dans lesquelles la composition chimique du lait est modifiée par des traitements non chimiques par des moyens électriques, p.ex. par électrodialyse
A23C 9/142 - Préparations à base de lait; Lait en poudre ou préparations à base de lait en poudre dans lesquelles la composition chimique du lait est modifiée par des traitements non chimiques par dialyse, osmose inverse ou ultrafiltration
A23L 33/00 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement
A23L 33/125 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
B01D 69/02 - Membranes semi-perméables destinées aux procédés ou aux appareils de séparation, caractérisées par leur forme, leur structure ou leurs propriétés; Procédés spécialement adaptés à leur fabrication caractérisées par leurs propriétés
NUTRICIA EARLY LIFE NUTRITION (SHANGHAI) CO., LTD. (Chine)
Inventeur(s)
Renes, Ingrid Brunhilde
Thomassen, Gabriel
Knol, Jan
Ludwig, Thomas
Jin, Haofang
Abrégé
Synergistic compositions for improving mineral bioaccessibility comprise lutein, casein phosphopeptide or 1,3-dioleoyl-2-palmitoylglycerol, preferably in combination with one or more of non-digestible oligosaccharides. The compositions can be used to prevent and/or treat mineral deficiency and associated conditions, preferably anaemia, said mineral comprises iron and/or calcium.
The invention relates to a nutritional composition comprising a combination of (i) co-enzyme Q10 with (ii) vitamin D and (iii) vitamin B2, for use in the treatment of stroke, preferably ischemic stroke. The invention also relates to a composition comprising a combination of co-enzyme Q10 and vitamin D, and vitamin D3 with optionally polyunsaturated fatty acids selected from DHA, EPA and/or DPA; and/or choline, choline salts and/or choline esters.
A61K 31/519 - Pyrimidines; Pyrimidines hydrogénées, p.ex. triméthoprime condensées en ortho ou en péri avec des hétérocycles
A61P 9/10 - Médicaments pour le traitement des troubles du système cardiovasculaire des maladies ischémiques ou athéroscléreuses, p.ex. médicaments antiangineux, vasodilatateurs coronariens, médicaments pour le traitement de l'infarctus du myocarde, de la rétinopathie, de l'insuffisance cérébro-vasculaire, de l'artériosclérose rénal
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61K 31/197 - Acides carboxyliques, p.ex. acide valproïque ayant un groupe amino les groupes amino et carboxyle étant liés à la même chaîne carbone acyclique, p.ex. acide gamma-aminobutyrique (GABA), bêta-alanine, acide epsilon-aminocaproïque, acide pantothénique
A61K 31/202 - Acides carboxyliques, p.ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p.ex. acides stéarique, palmitique ou arachidique ayant au moins trois doubles liaisons, p.ex. acide linolénique
A61K 31/375 - Acide ascorbique, c. à d. vitamine C; Ses sels
A61K 31/4188 - 1,3-Diazoles condensés avec des systèmes hétérocycliques, p.ex. biotine, sorbinil
A61K 31/455 - Acide nicotinique, c. à d. niacine; Ses dérivés, p.ex. esters, amides
A61K 33/04 - Soufre, sélénium ou tellure; Leurs composés
A61K 33/06 - Aluminium, calcium ou magnésium; Leurs composés
A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p.ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence
72.
NUTRITIONAL COMPOSITION FOR NEURODEGENERATION AND NEUROTRAUMA
The invention relates to a nutritional composition comprising a combination of (i) omega-3 fatty acid DHA with (ii) vitamin B2 and (iii) vitamin D3 for use in the treatment of neurodegenerative diseases and/or neurotrauma. The invention also relates to a composition comprising a combination of DHA, vitamin B2, vitamin D3 with optionally one or more from (iv) choline or a salt thereof and/or choline esters; and (v) dietary fibres and/or dietary butyrate.
A61K 31/197 - Acides carboxyliques, p.ex. acide valproïque ayant un groupe amino les groupes amino et carboxyle étant liés à la même chaîne carbone acyclique, p.ex. acide gamma-aminobutyrique (GABA), bêta-alanine, acide epsilon-aminocaproïque, acide pantothénique
A61K 31/202 - Acides carboxyliques, p.ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p.ex. acides stéarique, palmitique ou arachidique ayant au moins trois doubles liaisons, p.ex. acide linolénique
A61K 31/375 - Acide ascorbique, c. à d. vitamine C; Ses sels
A61K 31/4188 - 1,3-Diazoles condensés avec des systèmes hétérocycliques, p.ex. biotine, sorbinil
A61K 33/04 - Soufre, sélénium ou tellure; Leurs composés
A61K 33/06 - Aluminium, calcium ou magnésium; Leurs composés
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p.ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence
73.
LUTEIN FOR USE IN INHIBITING MAST CELL DEGRANULATION
NUTRICIA EARLY LIFE NUTRITION (SHANGHAI) CO., LTD. (Chine)
Inventeur(s)
Knipping, Catharina Theresia
Garssen, Johan
Ludwig, Thomas
Buurman, Nicole
Jin, Haofang
Abrégé
It relates to nutritional compositions comprising lutein for inhibiting mast cell degranulation, thereby preventing or treating symptoms or disorders associated with mast cell degranulation. Preferably, the compositions comprise lutein and non-digestible carbohydrates, such as those selected from prebiotic oligosaccharides, human oligosaccharides and combinations thereof.
A nutritional composition comprising digestible carbohydrates, protein and lipid, wherein the lipid comprises phospholipids, for use in improving the cognitive development in an infant born to a mother with hyperglycemia during pregnancy.
The invention concerns a native whey protein composition with profound amounts of native whey protein and with beta-casein for use in the treatment and/or prevention of gastrointestinal intolerance. The inventors found that the native whey protein composition relatively high in beta-casein and low in kappa- and alpha-casein provides a beneficial effect on gastrointestinal intolerance.
A23C 21/06 - Mélanges de petit-lait avec des produits laitiers ou des constituants du lait
A23C 9/142 - Préparations à base de lait; Lait en poudre ou préparations à base de lait en poudre dans lesquelles la composition chimique du lait est modifiée par des traitements non chimiques par dialyse, osmose inverse ou ultrafiltration
NUTRICIA EARLY LIFE NUTRITION (SHANGHAI) CO., LTD. (Chine)
Inventeur(s)
Wopereis, Harm Johannes
Roeselers, Guus
Liu, Mengjin
Jin, Yi
Abrégé
The invention pertains to a composition for use in increasing the relative abundance of Bacteroides and Parabacteroides in the intestinal microbiota of an infant that was delivered by Caesarean section or of an infant that was exposed to antibiotics early in life (e.g. intrapartum antibiotic prophylaxis (IAP) ), preferably an infant that was delivered by Caesarean section, wherein the composition comprises Bifidobacterium breve and non‐digestible oligosaccharide (s).
The invention relates to a nutritional composition selected from infant milk formulation, follow-on milk formulation and growing-up milk formulation for use in preventing or reducing programmed obesity after early childhood in female subjects that are overfed during infancy, wherein the nutritional composition comprises phospholipids, sphingolipids and cholesterol.
The present invention relates to formulae for infants comprising large lipid globules and/or lipid globules with a coating of phospholipids for controlling and reducing blood pressure in childhood.
Described is a feeding device, feeding system and method for determining a location of a feeding tube. In particular, the invention relates to a feeding device and method determining a location of a distal end of the feeding tube based on a pressure correlation between respective pressures measured by a distal end pressure sensor and another pressure sensor located further to a proximal end of the tube.
A card based container has a tubular sidewall of laminate material and first and second end closures, sealed to the tubular sidewall to form a hermetically sealed package. The sidewall comprises an outer card layer, an inner hygienic layer and one or more sealing strips provided at an inner surface of the inner hygienic layer, located at connection locations where the sidewall seals to itself or to the respective end closures. The sealing strips comprises a heat-sealable polymer. The overall amount of non-paper content in the sidewall and in the package may thus be reduced.
B65D 3/10 - Réceptacles rigides ou semi-rigides ayant un corps ou des parois périphériques de section transversale courbe ou partiellement courbe, réalisés en enroulant ou courbant du papier sans plier selon des lignes définies caractérisés par la forme de la fermeture d'extrémité faisant corps ou fixée à demeure
B65D 3/26 - Dispositifs d'ouverture incorporés dans ou fixés aux réceptacles
B65D 51/20 - Capuchons, couvercles ou chapeaux fonctionnant avec une fermeture intérieure disposée pour être ouverte en perçant, coupant ou déchirant
B65D 77/20 - Fermetures des réceptacles formées après remplissage en appliquant des couvercles ou chapeaux séparés
A card based container has a tubular sidewall of laminate material and first and second end closures, sealed to the tubular sidewall to form a hermetically sealed package. The sidewall comprises an outer card layer, an inner hygienic layer and one or more sealing strips provided at an inner surface of the inner hygienic layer, located at connection locations where the sidewall seals to itself or to the respective end closures. The sealing strips comprises a heat-sealable polymer. The overall amount of non-paper content in the sidewall and in the package may thus be reduced.
B65D 3/10 - Réceptacles rigides ou semi-rigides ayant un corps ou des parois périphériques de section transversale courbe ou partiellement courbe, réalisés en enroulant ou courbant du papier sans plier selon des lignes définies caractérisés par la forme de la fermeture d'extrémité faisant corps ou fixée à demeure
B65D 3/26 - Dispositifs d'ouverture incorporés dans ou fixés aux réceptacles
B65D 51/20 - Capuchons, couvercles ou chapeaux fonctionnant avec une fermeture intérieure disposée pour être ouverte en perçant, coupant ou déchirant
B65D 77/20 - Fermetures des réceptacles formées après remplissage en appliquant des couvercles ou chapeaux séparés
The invention pertains to a nutritional composition comprising therapeutically effective amounts of a combination of (a) hydrolysed whey protein and (b) MCT for use in (i) reducing tumor growth and/or (ii) for use in improving treatment efficacy in a subject having cancer and undergoing cancer treatment.
The invention provides a method, system, and computer program product for determining a maturation state of an infant aged between 0 and 120 months, comprising: measuring at least one microbial biomarker from a set of measurable microbial biomarkers from a faecal sample of the infant; determining a predicted age of the infant based on the at least one microbial biomarker; wherein the at least one microbial biomarker is selected from the set of measurable microbial biomarkers based on an analysis of the set of measurable microbial biomarkers as measured in faecal samples from a plurality of vaginally-born breast-fed infants at a plurality of ages, the predicted age is obtained based on an evaluation of the at least one measured microbial biomarker using a function based on a plurality of corresponding at least one biomarkers measured in the faecal samples from the plurality of vaginally-born breast-fed infants at the plurality of ages.
C12Q 1/04 - Détermination de la présence ou du type de micro-organisme; Emploi de milieux sélectifs pour tester des antibiotiques ou des bactéricides; Compositions à cet effet contenant un indicateur chimique
C12Q 1/68 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismes; Compositions à cet effet; Procédés pour préparer ces compositions faisant intervenir des acides nucléiques
G01N 33/569 - Tests immunologiques; Tests faisant intervenir la formation de liaisons biospécifiques; Matériaux à cet effet pour micro-organismes, p.ex. protozoaires, bactéries, virus
The invention relates to a first composition providing at least one of acetic acid or butyric acid for controlling ketosis associated with a ketogenic diet in a subject adhering to a ketogenic diet, wherein controlling ketosis involves a) administering the first composition, b) optionally administering a second composition comprising propionic acid to reduce ketone production/ administering a second composition comprising propionic acid provided that blood ketone levels are above (3) mmol/L.
A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p.ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle
A61P 1/16 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des troubles de la vésicule biliaire ou du foie, p.ex. protecteurs hépatiques, cholagogues, cholélitholytiques
A61P 3/00 - Médicaments pour le traitement des troubles du métabolisme
A61P 9/00 - Médicaments pour le traitement des troubles du système cardiovasculaire
A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
The present invention relates to propionic acid for decreasing ketone production and/or preventing and/or treating ketoacidosis in a human subject in need thereof and wherein said subject is administered therapeutically effective amounts of propionic acid, preferably in a range of 1 mg to 1200 mg propionic acid per day.
A61P 1/16 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des troubles de la vésicule biliaire ou du foie, p.ex. protecteurs hépatiques, cholagogues, cholélitholytiques
A61P 3/00 - Médicaments pour le traitement des troubles du métabolisme
86.
NEUROPROTECTIVE COMPOSITION COMPRISING PYRUVATE AND CITRATE
The invention relates to a neuroprotective composition comprising therapeutically effective amounts of a combination of pyruvate and citrate, for the treatment and/or prevention of neuronal damage in a subject suffering from or at risk of seizures.
The invention relates to at least one of C4 or C6 fatty acids and optionally C2 fatty acids for enhancing ketosis associated with a ketogenic diet and/or preventing and/or treating resistance to a ketogenic diet, in a subject adhering to a ketogenic diet, wherein the at least one of C4 or C6 fatty acids and optionally C2 fatty acids are comprised in a non-ketogenic ketogenic diet-booster composition, or the at least C4 or C6 fatty acids and optionally C2 fatty acids are provided in non-ketogenic amounts by a dietary fibre blend comprised in a non-ketogenic ketogenic diet-booster composition.
A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p.ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle
A61P 1/16 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des troubles de la vésicule biliaire ou du foie, p.ex. protecteurs hépatiques, cholagogues, cholélitholytiques
A61P 3/00 - Médicaments pour le traitement des troubles du métabolisme
A61P 9/00 - Médicaments pour le traitement des troubles du système cardiovasculaire
A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
A consortium of specific probiotic bacteria comprising Bifidobacterium bifidum and Bifidobacterium breve with specific carbohydrate degrading properties, specific human milk oligosaccharide and preferably also beta-galacto-oligosaccharides with a higher degree of polymerization, is particularly effective for improving intestinal microbiota resilience.
The present invention concerns a process for producing a dry cereal composition, comprising (a) fermenting phytic acid containing cereals by phytase-positive lactic acid bacteria at a temperature below 45° C., until a pH of at most 5.9 is reached, (b) heating the fermented cereals obtained in step (a) to a temperature in the range of 40-55° C., for a period of at least 1.5 h; (c) drying the fermented and phytase treated cereals originating from step (b) to obtain the dry cereal composition. The present invention is ideally suited to reduce the phytate content of fermented cereals, thereby increasing the bio-availability of minerals. The invention further contains the dry cereal composition obtainable by the process according to the invention, especially having a molar ratio of phytate to iron of at most 1, and the use thereof in increasing the bio-availability of minerals.
The invention concerns a process of preparing an allergenic, edible powder product suitable for introducing or reintroducing protein to a human subject allergic to the protein or at risk of becoming allergic to the protein, the process comprising: (a) providing a powder comprising protein and reducing sugar, wherein the powder comprises a milk protein comprising beta-lactoglobulin (BLG), preferably BLG-A; and (b) heating the powder of step (a) (homogeneously) within a heated, vibrating pipe, wherein the powder is heated at a temperature from 60 to 150 °C, preferably from 70 to 120 °C, more preferably from 70 to 100 °C, wherein the relative humidity (RH) within the pipe is controlled below 80%, to obtain a powder wherein the protein has been glycated with the reducing sugar; (c) optionally adding any heat-sensitive components and/or bulking agents to the powder after step (b), (d) packaging the powder, to obtain a packaged amount of an allergenic, edible powder: (i) having a (predetermined) antigenicity reduced at least 20% compared to the protein reference; and/or (ii) wherein the glycated protein has a (predetermined) degree of glycation of at least 5% expressed as the percentage of lysine residues that are blocked by the reducing sugar on BLG, preferably BLG-A, wherein the powder is preferably characterized by at least (ii).
A23L 27/21 - ALIMENTS, PRODUITS ALIMENTAIRES OU BOISSONS NON ALCOOLISÉES NON COUVERTS PAR LES SOUS-CLASSES OU ; LEUR PRÉPARATION OU TRAITEMENT, p.ex. CUISSON, MODIFICATION DES QUALITÉS NUTRITIVES, TRAITEMENT PHYSIQUE ; CONSERVATION DES ALIMENTS OU PRODUITS ALIMENTAIRES EN GÉNÉRAL Édulcorants artificiels; Sels de table; Substituts diététiques du sel; Leur préparation ou leur traitement Épices, agents aromatiques ou condiments synthétiques contenant des acides aminés
A23C 9/00 - Préparations à base de lait; Lait en poudre ou préparations à base de lait en poudre
A23C 9/18 - Lait sous la forme d'un produit comprimé sec ou semi-solide
A23L 33/00 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement
A23C 9/16 - Agglomération ou granulation du lait en poudre; Fabrication du lait en poudre à solubilité instantanée; Produits obtenus
A23C 11/10 - Succédanés du lait, p.ex. compositions pour remplacer le lait dans le café au lait contenant au moins un composé d'origine non laitière comme source de matières grasses ou de protéines contenant ou non du lactose mais pas d'autre composé d'origine laitière comme source de matières grasses, d'hydrates de carbone ou de protéines
A23C 21/00 - Petit-lait; Préparations à base de petit-lait
Method for providing a container with food, the method comprising: providing a container for infant formula food, adding the food, sealing the container with a gas-tight membrane seal, adding an inner scannable code on the gas-tight membrane seal, closing the container with a tamper-proof closure means, so that the inner scannable code is not scannable without breaking a part of the tamper-proof closure means, and storing the inner scannable code in a database.
G06Q 30/018 - Certification d’entreprises ou de produits
B65B 1/04 - Procédés ou moyens pour remplir les réceptacles ou les récipients avec le matériau
B65B 7/28 - Fermeture de réceptacles ou récipients semi-rigides ou rigides, non déformés par le contenu ou n'en prenant pas la forme, p.ex. boîtes ou cartons en appliquant des fermetures séparées préformées, p.ex. couvercles, capuchons
B65B 61/26 - Dispositifs accessoires, non prévus ailleurs, opérant sur feuilles, flans, bandes, attaches, réceptacles ou paquets pour marquer ou coder les paquets achevés
B65D 43/16 - Couvercles ou chapeaux inamovibles s'ouvrant à charnières vers le haut ou vers le bas
B65D 51/20 - Capuchons, couvercles ou chapeaux fonctionnant avec une fermeture intérieure disposée pour être ouverte en perçant, coupant ou déchirant
B65D 51/24 - Fermetures non prévues ailleurs combinées avec dispositifs auxiliaires pour des buts autres que la fermeture
G06K 7/14 - Méthodes ou dispositions pour la lecture de supports d'enregistrement par radiation corpusculaire utilisant la lumière sans sélection des longueurs d'onde, p.ex. lecture de la lumière blanche réfléchie
G06K 19/06 - Supports d'enregistrement pour utilisation avec des machines et avec au moins une partie prévue pour supporter des marques numériques caractérisés par le genre de marque numérique, p.ex. forme, nature, code
G06Q 10/0639 - Analyse des performances des employés; Analyse des performances des opérations d’une entreprise ou d’une organisation
94.
ELECTRONIC DEVICE AND METHOD FOR DETERMINING HUMAN HEIGHT USING NEURAL NETWORKS
Electronic device for estimating a height of a human, the electronic device comprising: a processor configured to: obtain an image including at least a part of a representation of the human and reference information; input the image to a first neural network and obtain as output from the first neural network first information, the first information related to a plurality of keypoints in the body of the human; input the image to a second neural network and obtain as output from the second neural network second information, the second information related to the reference information; and estimate the height of the human based on the first information and the second information; and an output unit configured to output the estimated height.
The invention pertains to a solid composition suitable for treating adult animals that suffer from brain-related disorders, brain-related decline or brain-related diseases, preferably suitable for treating adult animals that suffer from brain-related disorders, the composition containing (i) a uridine source, wherein the amount of the sum of all uridine sources, calculated on the basis of the weight of the molar equivalent of uridine monophosphate (UMP), is 0.3-15 g per 100 g dry weight of the composition, (ii) a polyunsaturated fatty acid, preferably an omega-3 polyunsaturated fatty acid, (iii) choline bitartrate, (iv) a buffering salt component, and (v) a milk protein source, wherein the milk protein source is a milk powder, and the buffering salt component containing at least one food approved salt, with a buffering capacity between pH 5 – 8, the buffering salt component preferably containing a mixture of food-approved salts, or a food-approved salt and its conjugated acid or base.
A61K 31/202 - Acides carboxyliques, p.ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p.ex. acides stéarique, palmitique ou arachidique ayant au moins trois doubles liaisons, p.ex. acide linolénique
A61K 31/7072 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p.ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle contenant des pyrimidines condensées ou non-condensées ayant des groupes oxo liés directement au cycle pyrimidine, p.ex. cytidine, acide cytidylique ayant deux groupes oxo liés directement au cycle pyrimidine, p.ex. uridine, acide uridylique, thymidine, zidovudine
A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p.ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence
96.
Formula with galactomannan gum and non digestible oligosaccharides
The present invention relates to anti-regurgitation formula with locust bean gum and non-digestible oligosaccharides for improved effect on functional gastro-intestinal disorders in infants and young children.
A23L 33/00 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement
A23L 29/244 - Aliments ou produits alimentaires contenant des additifs; Leur préparation ou leur traitement contenant des agents gélifiants ou épaississants d'origine végétale à partir de bulbes, de tubercules ou de racines, p.ex. glucomannane
A23L 33/21 - Adjonction de substances essentiellement non digestibles, p.ex. de fibres diététiques
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Dietetic food adapted for special medical purposes; dietetic foods and beverages and preparations adapted for medical purposes; food for babies; food for patients and sick persons in the nature of dietetic foods adapted for medical purposes; infant formula; food for babies with special nutritional needs; liquid and powdered non-dairy and plant-based milks for babies, namely, milks derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits; nutritional products for medical purposes, namely, nutritionally fortified beverages; nutritional supplements; cereals for infants in the nature of food for babies; vitamin preparations; dietetic foods adapted for medical purposes for pregnant, lactating and breast feeding women; dietetic milk adapted for medical purposes for pregnant, lactating and breast feeding women; dietary fiber to aid digestion; protein dietary supplements; soy protein dietary supplements; protein supplements shakes; energy bars used as food supplements; dietary supplements for human beings
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Dietetic food for special medical purposes; dietetic foods and substances adapted for medical purposes; food for babies; food for patients and sick persons in the nature of dietetic foods adapted for medical purposes; infant formula; food for babies with special nutritional needs; liquid and powdered non-dairy and plant-based milks for babies, namely, milks derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits; nutritional products for medical purposes, namely, nutritionally fortified beverages; nutritional supplements; cereals for infants in the nature of food for babies; vitamin preparations; dietetic foods adapted for medical purposes for pregnant, lactating and breast feeding women; dietetic milk adapted for medical purposes for pregnant, lactating and breast feeding women; dietary fiber to aid digestion; protein dietary supplements; soy protein dietary supplements; protein supplements shakes; energy bars used as food supplements; dietary supplements for human beings
99.
NUTRITIONAL COMPOSITION FOR MUSCLE MASS, STRENGTH AND FUNCTION
The invention pertains to a nutritional composition for use in prevention and/or treatment of whole body protein metabolism decline or whole body protein function decline, or for therapeutic use in improving whole body protein metabolism or whole body protein function, in a human subject, wherein the human subject is preferably an ageing human elderly subject of at least 40 years of age, wherein the composition comprises a protein fraction comprising 32-58wt% pea protein, 30-56wt% soy protein and 8-16wt% free leucine, preferably a protein fraction comprising 36-54wt% pea protein, 34-52wt% soy protein and 10-14wt% free leucine, and optionally up to 5wt% of free branched chain amino acids other than leucine, based on all proteinaceous matter, wherein the composition is essentially free from animal protein.
The present invention relates to a use of octenylsuccinyl anhydride substituted starch (OSA starch) for increasing the dry weight content and/or the fat content of a liquid composition that is subjected to a spray-drying step, and also to a process for preparing powders. The present invention enables the spray-drying of emulsions that contain a high amount of fat. The present invention also relates to the powder products obtainable by the process and nutritional products such as an infant milk powder, grow up milk, toddler milk or as a medical nutritional product that can be formulated therewith.
A23L 29/219 - Amidon chimiquement modifié; Produits de réaction ou de complexation de l’amidon avec d’autres produits chimiques
A23L 33/00 - Modification de la qualité nutritive des aliments; Produits diététiques; Leur préparation ou leur traitement
A23P 10/47 - Fabrication de poudres à écoulement libre ou instantanées, c. à. d. de poudres reconstituées rapidement par l’ajout d’un liquide utilisant des additifs, p.ex. des émulsifiants, des agents mouillants ou des agents liant la poussière
C11B 15/00 - Solidification des huiles, graisses, ou cires par des procédés physiques
